Abstract: Aspects relate to patterned nanostructures having a feature size not including film thickness of below 5 microns. The patterned nanostructures are made up of nanoparticles having an average particle size of less than 100 nm. A nanoparticle composition, which, in some cases, includes a binder, is applied to a substrate. A patterned mold used in concert with electromagnetic radiation function to manipulate the nanoparticle composition in forming the patterned nanostructure. In some embodiments, the patterned mold nanoimprints a pattern onto the nanoparticle composition and the composition is cured through UV or thermal energy. Three-dimensional patterned nanostructures may be formed. A number of patterned nanostructure layers may be prepared and joined together. In some cases, a patterned nanostructure may be formed as a layer that is releasable from the substrate upon which it is initially formed.

Abstract: Provided are a barium titanate powder having spherical shape fine particles which have an average particle diameter (D50) in a range of about 140-270 nm, a tetragonal structure having a markedly improved tetragonality (c/a) in a range of 1.007-1.01 in contrast to the conventional composition, and at the same time, a markedly improved crystallinity in a range of 93-96%, thereby showing improved dielectric properties, and a manufacturing method thereof.

Abstract: Processes and systems that utilize methane pyrolysis for carbon capture from a petrochemical stream that contains hydrogen and methane. The petrochemical stream can be the tail gas of a hydrocarbon cracking system, or any other petrochemical stream containing hydrogen and methane. The petrochemical stream can be separated into a hydrogen product stream and a methane product stream, before sending the methane product stream to a methane pyrolysis unit. The methane pyrolysis unit converts methane to solid carbon and hydrogen.

Abstract: The present invention relates to reconstituted high density lipoprotein (rHDL) formulations comprising an apolipoprotein, a lipid and a lyophilization stabilizer. Said formulations have reduced renal toxicity and good long-term stability, especially in lyophilized form.

Abstract: Provided are a negative electrode active material including a three-dimensional composite. The three-dimensional composite includes secondary particles containing a silicon carbide-based (SiCx, 0<x?1) nanosheet having a bent portion and amorphous carbon. Also provided are a method of producing the same, and a negative electrode and a lithium secondary battery including the negative electrode active material.

Abstract: A carbon nanoparticle and methods of making and using a carbon nanoparticle are provided. The carbon nanoparticle includes a reaction product of an organic reactant, an alkoxy amine, and an organometallic compound. The organometallic compound includes an element selected from the group consisting of a rare earth element, a transition metal element, and combinations thereof, and the carbon nanoparticle includes from 0.5 to 50 wt. % of the element. A method of making the carbon nanoparticle is also provided. The method includes combining the organic reactant, the alkoxy amine, and the organometallic compound into a mixture and heating the mixture such that the carbon nanoparticle forms. A method of determining a flow characteristic of a formation or an attribute of a fluid in a formation using the carbon nanoparticle is also provided.

Abstract: An Fe-based amorphous alloy ribbon reduced in iron loss, less deformed, and highly productive in a condition of a magnetic flux density of 1.45 T is provided. One aspect of the present disclosure provides an Fe-based amorphous alloy ribbon having first and second surfaces, and is provided with continuous linear laser irradiation marks on at least the first surface. Each linear laser irradiation mark is formed along a direction orthogonal to a casting direction of the Fe-based amorphous alloy ribbon, and has unevenness on its surface. When the unevenness is evaluated in the casting direction, a height difference HL×width WA calculated from the height difference between a highest point and a lowest point in a thickness direction of the Fe-based amorphous alloy ribbon and the width WA which is a length of the linear irradiation mark on the first surface is 6.0 to 180 ?m2.

Abstract: Provided is a stable pharmaceutical composition for oral administration comprising 6-ethyl-3-({3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)-5-(tetrahydro-2H-pyran-4-ylamino)pyrazine-2-carboxamide (hereinafter referred to as compound A) or a pharmaceutically acceptable salt thereof, wherein the generation of related substances during storage is inhibited. In the stable pharmaceutical composition for oral administration, the proportion of crystals of compound A or a pharmaceutically acceptable salt thereof is 60% or more with respect to the total amount of compound A or a pharmaceutically acceptable salt thereof.

Abstract: Disclosed herein are embodiments of a polymer-functionalized particle for using in isolating and extracting solutes, such as rare earth metals, lithium, and the like. The polymer-functionalized particles exhibit strong resistance to agglomeration and degradation even in high ionic strength and/or temperature environments. A post-particle synthesis method for making the polymer-functionalized particle is disclosed, along with a magnetic separation device and that can be used in system embodiments to facilitate use and regeneration of the polymer-functionalized particles in solute extraction.

Abstract: Provided is a stable pharmaceutical composition for oral administration comprising 6-ethyl-3-({3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)-5-(tetrahydro-2H-pyran-4-ylamino)pyrazine-2-carboxamide (hereinafter referred to as compound A) or a pharmaceutically acceptable salt thereof, wherein the generation of related substances during storage is inhibited. In the stable pharmaceutical composition for oral administration, the proportion of crystals of compound A or a pharmaceutically acceptable salt thereof is 60% or more with respect to the total amount of compound A or a pharmaceutically acceptable salt thereof.

Abstract: Provided is a stable pharmaceutical composition for oral administration comprising 6-ethyl-3-({3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)-5-(tetrahydro-2H-pyran-4-ylamino)pyrazine-2-carboxamide (hereinafter referred to as compound A) or a pharmaceutically acceptable salt thereof, wherein the generation of related substances during storage is inhibited. In the stable pharmaceutical composition for oral administration, the proportion of crystals of compound A or a pharmaceutically acceptable salt thereof is 60% or more with respect to the total amount of compound A or a pharmaceutically acceptable salt thereof.

Abstract: Provided is a stable pharmaceutical composition for oral administration comprising 6-ethyl-3-(3-methoxy-4-4-(4-methylpiperazin-1-yl)piperidin-1-yl phenylamino)-5-(tetrahydro-2H-pyran-4-ylamino)pyrazine-2-carboxamide (hereinafter referred to as compound A) or a pharmaceutically acceptable salt thereof, wherein the generation of related substances during storage is inhibited. In the stable pharmaceutical composition for oral administration, the proportion of crystals of compound A or a pharmaceutically acceptable salt thereof is 60% or more with respect to the total amount of compound A or a pharmaceutically acceptable salt thereof.

Abstract: Provided is a stable pharmaceutical composition for oral administration comprising 6-ethyl-3-({3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)-5-(tetrahydro-2H-pyran-4-ylamino)pyrazine-2-carboxamide (hereinafter referred to as compound A) or a pharmaceutically acceptable salt thereof, wherein the generation of related substances during storage is inhibited. In the stable pharmaceutical composition for oral administration, the proportion of crystals of compound A or a pharmaceutically acceptable salt thereof is 60% or more with respect to the total amount of compound A or a pharmaceutically acceptable salt thereof.

Abstract: Composite material can include a matrix material, a fiber dispersed in the matrix material, and an ultraviolet (UV)-light sensitive mechanophore grafted to a surface of the fiber. A method for making a fiber-reinforced polymer composite can include contacting a fiber in a first solution, rinsing and then drying intermediate fiber, contacting dried fiber in a third solution, rinsing, and then drying the rinsed fiber thereby generating functionalized fiber that is sensitive to ultraviolet light. The functionalized fiber can be combined with a polymer matrix material, cured, and irradiated, thereby generating a fiber-reinforced polymer composite.

Abstract: An embodiment of the present invention provides an optical film (10) including a light-transmitting base material (11), a hard coat layer (12), and an inorganic layer (13) in this order, wherein the hard coat layer (12) is in contact with the inorganic layer (13), the hard coat layer (12) contains a binder resin (12A) and inorganic particles (12B), the hard coat layer (12) has a film thickness of 1 ?m or more, and the hard coat layer (12) has an indentation hardness of 200 MPa or more.

Abstract: A spectrometer and a fabrication method thereof. The spectrometer includes: a first base substrate; a second base substrate opposite to the first base substrate; a detection channel between the first base substrate and the second base substrate; a quantum dot light emitting layer on a side of the first base substrate that is close to the second base substrate, and including a plurality of quantum dot light emitting units; a black matrix on the side of the first base substrate that is close to the second base substrate, and configured to separate the plurality of quantum dot light emitting units; and a sensor layer, including a plurality of sensors, the plurality of sensors being in one-to-one correspondence with the plurality of quantum dot light emitting units.

Abstract: The present disclosure relates to a fine particle-trapping sensor including: a plasmonic hotspot layer formed of a first metal; and a trapping layer formed of a second material. The inventors of the present disclosure have made extensive research efforts to develop a more effective and novel sensor for the real-time and high-sensitivity detection of droplets emitted from the oral cavity. As a result, the inventors have developed an alloy composite nanostructure including a Raman sensor layer, formed of a metal, and a trapping layer formed of a dielectric material, and have found that, when the ratio between the two layers is adjusted, the alloy composite nanostructure effectively traps respiratory droplets rapidly emitted from the oral cavity and detects coronavirus (SARS-CoV-2 lysate) in the respiratory droplets at a concentration of 10 pfu/ml, indicating that the composite nanostructure may be very advantageously used in the field of fine particle trapping.

Abstract: A quantum dot-polymer composite pattern including at least one repeating section configured to emit light of a predetermined wavelength, and a production method and a display device including the quantum dot-polymer composite are disclosed. The quantum dot-polymer composite includes a polymer matrix including linear polymer including a carboxylic acid group-containing repeating unit and a plurality of cadmium-free quantum dots dispersed in the polymer matrix, has an absorption rate of greater than or equal to about 85% for light at wavelength of about 450 nm, and has an area ratio of a hydroxy group peak relative to an acrylate peak of greater than or equal to about 2.6 in Fourier transform infrared spectroscopy.

Abstract: A photocurable composition includes quantum dots, quantum dot precursor materials, a chelating agent, one or more monomers, and a photoinitiator. The quantum dots are selected to emit radiation in a first wavelength band in the visible light range in response to absorption of radiation in a second wavelength band in the UV or visible light range. The second wavelength band is different than the first wavelength band. The quantum dot precursor materials include metal atoms or metal ions corresponding to metal components present in the quantum dots. The chelating agent is configured to chelate the quantum dot precursor materials. The photoinitiator initiates polymerization of the one or more monomers in response to absorption of radiation in the second wavelength band.

Abstract: An anti-glare film is prepared which have a ratio R/V of a scattered specular reflection intensity R to a total V of scattered reflection intensity being from 0.01 to 0.12 and an absolute value of a chromaticity b* of transmitted light being 3 or less. The anti-glare film includes a transparent substrate layer, and an anti-glare layer formed on at least one surface of the transparent substrate layer. The anti-glare layer may be a cured product of a curable composition including one or more types of a polymer component and one or more types of a curable resin precursor component, and in particular, at least two components selected from a polymer component and a curable resin precursor component can be phase separated through liquid phase spinodal decomposition. This anti-glare film can achieve non-coloring properties and anti-glare properties in a compatible manner.

Abstract: An oil-based formulation comprising a cannabinoid and pico size carbon particles. The formulation is suitable for administration to a patient having a medical condition requiring the use of cannabinoid.

Abstract: A transparent conductive layer 3 includes a first main surface 5 exposed to the outside, and a second main surface 6 opposite to the first main surface 5 in a thickness direction. The transparent conductive layer 3 is single layer extending in a plane direction. The transparent conductive layer 3 has a first grain boundary 7 in which two end edges 23 in a cross-sectional view are open to the first main surface 5, and an intermediate region 25 between both end edges 23 is not in contact with the second main surface 6, and has a first crystal grain 31 partitioned by the first grain boundary 7 and facing only the first main surface 5.

Abstract: A composite structure is provided that includes a polymer layer and an auxetic material layer disposed within or partially within the polymer layer. The auxetic material layer provides increased conductivity and elastomeric reinforcement to the polymer layer.

Abstract: Techniques for controlling the flow of replication material (e.g., epoxy) during the formation of replicated optical elements include providing a transparent substrate (220) onto which the optical elements are to be replicated. The substrate (220) includes a structured UV curable shield (202) adhering to its surface. The UV curable shield (202), in turn, has openings (203) that expose portions of the surface of the transparent substrate (220) for replication of the optical elements. During the replication process, excess replication material (124A) may flow onto the UV curable shield (202), which subsequently can be cured so as to facilitate the release and removal of the shield (202) along with the excess replication material (124A).

Abstract: The present invention combines the advantages of fabrication of semiconductor heterostructure (Ag3PO4—WO3) with plasmonic metals (Pt and Ag) with optical interference to optimize the visible light photo response of plasmonic metals deposited semiconductor (Pt—Ag/Ag3PO4—WO3) for visible light assisted H2 generation utilizing the aqueous bio-alcohols. Crystalline Ag3PO4 and WO3 nanofibers were synthesized by microwave and electrospinning methods. Three different WO3 nanofibers composition (5, 10 and 15 wt. %) were used to obtain Ag3PO4/WO3 nanocomposite heterostructures, which are effective visible light active photo catalysts. Further, a simple, enviro-friendly, and cost-effective biogenic synthesis method have been achieved using Salvia officinalis extract to decorate Pt and Ag metal nanoparticles on the surface of Ag3PO4—WO3 composites. Presence of bioactive agents in the extract are responsible for the Pt and Ag3PO4 reduction and for prevention of the Pt nanoparticles from aggregation in aqueous medium.

Abstract: A method, system, apparatus, and/or device with a miniaturized impedance sensor. The method, system, apparatus, and/or device may include a substrate with locally non-flexible regions interconnected by a flexible material and a miniaturized impedance sensor disposed on the substrate. The miniaturized impedance sensor may include: an array of electrical contacts; an array of miniaturized electrodes disposed on the array of electrical contacts; and an interstitial filler disposed within the array of miniaturized electrodes. The locally non-flexible regions may correspond to subsets of the array of miniaturized electrodes. The locally non-flexible regions may retain shape as the flexible material changes shape.

Abstract: Serial-solvent biomaterials are described. Embodiments include materials made in an organic solvent that are stripped of the solvent and used in a patient, where they imbibe water and form a hydrogel. These materials are useful for, among other things, delivering therapeutic agents, tissue augmentation, and radiological marking.

Abstract: According to various aspects of the present disclosure, a catalyst for rechargeable energy storage devices having a first transition metal and a second transition metal, wherein the first and second transition metals are formed on carbon nanotubes, the carbon nanotubes are doped with nitrogen and phosphorous, wherein the carbon nanotubes have edges and interlayer spaces and are axially aligned, and the first and second transition metals form bimetal centers, wherein the bimetal centers may be uniformly distributed catalytic active sites located at the edges or the interlayer spaces of the carbon nanotubes providing intercalated layers. The present FeCo—NPCNTs are a morphology-dependent catalyst that provides effective performance for bifunctional oxygen reduction reaction and oxygen evolution reaction in metal-air-cells and fuel cells.

Abstract: The present disclosure relates to a method for making a ceramic mini-tube configured for use in a fluid modification system. The method involves using an electrospinning system to receive a quantity of precursor solution. The electrospinning system creates an electric field which causes the precursor solution, when emitted, to be stretched into a fiber jet. The fiber jet is deposited on a collector resulting in a fiber mat. The fiber mat is removed from the collector, wherein the fiber mat is formed into a shape. The fiber mat is further processed so that the fiber mat retains a desired shape. A heat treatment operation is then performed to convert the fiber mat into a ceramic structure having the desired shape.

Abstract: A diffuser generates scattered light and satisfies MFP=1/(?×A2×Qs×N)=?Zd, 0.4???5 where N denotes a number of nanoparticles included in a unit volume of a light guiding and diffusing portion, A denotes an average particle radius of the nanoparticles, Qs denotes a scattering efficiency determined by a combination of the nanoparticles and a medium of the light guiding and diffusing portion, MFP denotes a mean free path for light of a design wavelength set in a range of 450 nm to 650 nm, Zd denotes a length of the light guiding and diffusing portion in a light guiding direction of incident light, and a denotes a coefficient.

Abstract: Disclosed is a coating composition which includes: polyurethane; and amphiphilic nanoparticles having an amine functional group and a fluorine functional group in their structure. Further provided are a polyurethane-silica composite film including e coating composition and a method of preparing the same.

Abstract: Embodiments described herein relate to compounds for the detection of wounds, e.g., chronic wounds or infected wounds, including compositions, substrates, kits, dressing materials, and articles, and systems containing such compounds. Further embodiments relate to methods of using these compositions, kits and systems in diagnostic assays, and in the diagnosis and/or detection of chronic or infected wounds based on enzymatic conversion of specific substrates which are contained in the compositions. Additional embodiments relate to methods of characterizing wounds based on expression of a plurality of markers and using such information to treat, manage, and follow-up patients suffering from chronic or infected wounds.

Abstract: A method for making a plasmonic mushroom array includes: forming a plurality of metal nano-islands each having nanometer-range dimensions on a surface of a glass substrate; and subjecting to the glass substrate having the plurality of metal nano-islands formed thereon to reactive ion etching such that the plurality of metal nano-islands are converted to a plurality of mushroom-shaped structures each having a metal cap supported by a pillar made of a material of the glass substrate and each having dimensions smaller than the dimensions of the nano-islands, the plurality of mushroom-shaped structures being arranged in a substantially regular pattern with intervals smaller than average intervals between the nano-islands, thereby forming the plurality of nano-scale mushroom-shaped structures on the glass substrate that can exhibit localized surface plasmon resonance.

Abstract: Provided is a lubricating oil composition including a lubricating oil additive and a lubricating oil, the lubricating oil additive having nanodiamonds, of which a surface is hydrophobically modified by a surface treatment, dispersed in a base oil. The lubricating oil composition retains dispersibility over a long period of time and thus can ensure storage stability. Machines to which the lubricating oil composition is applied may have improved abrasion resistance as well as improved fuel consumption and reduced noise, and high thermal conductivity of the lubricating oil composition may also increase cooling efficiency and the service life of machines.

Abstract: A method of producing a positive-electrode active material for a non-aqueous electrolyte secondary battery is provided. The method includes obtaining a precipitate containing nickel and manganese from a solution containing nickel and manganese, heat-treating the resulting precipitate at a temperature of from 850° C. to less than 1100° C. to obtain a first heat-treated product, mixing the first heat-treated product and a lithium compound, and heat-treating the resulting lithium-containing mixture at a temperature of from 550° C. to 1000° C. to obtain a second heat-treated product. The second heat-treated product contains a group of lithium transition metal composite oxide particles having an average particle diameter DSEM of from 0.5 ?m to less than 3 ?m and D50/DSEM of 1 to 2.5. The lithium transition metal composite oxide particles have a spinel structure based on nickel and manganese.

Abstract: An electroluminescent display device includes a substrate having an emission area and a transparent portion, the emission area including a sub-pixel, and the transparent portion being adjacent to the sub-pixel; a first electrode in the emission area and over the substrate; a transparent connection pattern in the transparent portion and over the substrate, the transparent connection pattern being spaced apart from the first electrode; a first bank covering an edge of the first electrode and exposing the transparent connection pattern in the transparent portion; and a second bank on the first bank and covering the transparent connection pattern in the transparent portion, wherein the second bank includes a transparent conductive material.

Abstract: Disclosed herein is a catalyst which comprises a silica core having an outer surface and a mesoporous silica shell having an outer surface and an inner surface with the inner surface being inside the outer surface of said mesoporous silica shell proximate to and surrounding the outer surface of said silica core. Wherein the outer surface of the mesoporous silica shell has openings leading to pores within the mesoporous silica shell which extend toward the outer surface of said silica core. The catalyst also includes catalytically active metal nanoparticles positioned within the pores proximate to said core, wherein the catalytic metal nanoparticles comprise about 0.0001 wt % to about 1.0 wt % of the catalyst. Also disclosed are methods of making the catalyst and using it to carry out a process for catalytically hydrogenolysizing a polyolefinic polymer.

Abstract: The core active components of the present composition, termed as de-ironizing inducers (DII), has a reducing agent and a precipitating agent. Molar ratios of the reducing agent with the precipitating agent range from 1:3-6 and the core components in the skincare product range from 0.1% to 10% w/w. The pH value of the skincare product is between 6.6 and 7.4. The skin care products can safely and effectively 5 remove iron in the skin, which has been shown to accelerate the visible signs of aging. The core components can also be used in combination with conventional skincare product compounds to achieve better anti-aging effects.

Abstract: A Mie photo sensor is described. A Mie photo sensor is configured to leverage Mie scattering to implement a photo sensor having a resonance. The resonance is based on various physical and material properties of the Mie photo sensor. In an example, a Mie photo sensor includes a layer of semiconductor material with one or more mesas. Each mesa of semiconductor material may include a scattering center. The scattering center is formed by the semiconductor material of the mesa being at least partially surround by a material with a different refractive index than the semiconductor material. The abutting refractive index materials create an interface that forms a scattering center and localizes the generation of free carriers during Mie resonance. One or more electrical contacts may be made to the mesa to measure the electrical properties of the mesa.

Abstract: A zirconia ceramic material for use in dental applications is provided comprising an yttria-stabilized zirconia material comprising from 4.5 mol % to 5.1 mol % yttria. Optionally, the zirconia ceramic has a coloring agent that may comprise one or more metals selected from terbium (Tb), chromium (Cr), erbium (Er), and cobalt (Co), and further, may, optionally, comprise alumina, which if present may be in an amount from 0 wt % to 0.25 wt %. The zirconia ceramic materials exhibit both enhanced translucency and a flexural strength of at least 800 MPa when fully sintered.

Abstract: A self-assembled discoidal PNA delivery vehicle includes a zwitterionic short chain diacyl lipid, a zwitterionic long chain diacyl lipid, a charged long chain diacyl lipid, a PEGylated lipid of the formula distearoyl phosphoethanolamine (DSPE)-PEGn-TG, and an encapsulated PNA molecule with a defined molar ratio of the zwitterionic long chain diacyl lipid and the charged long chain diacyl lipid to the short chain diacyl lipid, the molar ratio of the charged long chain diacyl lipid to the zwitterionic long chain diacyl lipid, molar % of the PEGylated lipid to all lipids, and ratio of PNA to lipid. Also described are method of self-assembling the discoidal PNA delivery vehicle and methods of enhancing cellular uptake of PNA using the discoidal PNA delivery vehicle.

Abstract: Mechanically strong, biodegradable and reusable aerogels are disclosed, which can be made with a cross-linked cellulose ester, and which exhibit a low density and high porosity. The aerogels disclosed herein may be used as sorbent materials and can be modified with a hydrophobic and/or oleophilic agent.

Abstract: An optical coherence tomography (OCT) scan device includes an OCT scan device housing, an interferometer disposed within the OCT scan device housing and including a light source, a fiber optic coupler including an interferometer output, a reference-arm, and a sample-arm. The OCT scan device further includes a power source configured to provide power to the light source and the remaining components of the OCT scan device, and a controller disposed within the OCT scan device housing and configured to adjust lens focusing parameters in the reference-arm and the sample-arm, and control a scanning function of an optical beam emitting from the sample-arm. The OCT scan device is further configured to transmit and receive control instructions and transmit fundus image data.

Abstract: The present invention addresses the problem of providing a method that enables easy manufacturing of silver nanowires which have an average diameter smaller than those obtained from methods in the related art and in which the proportion of large diameter silver nanowires is reduced. Provided is a method for manufacturing silver nanowires, in which the silver nanowires are obtained from a silver salt using the silver salt, a halide salt, and a growth control agent in a polyol, and at least one selected from the group consisting of ?-angelica lactone, phthalide, and a compound represented by General Formula (1) below (in General Formula (1), R1 and R3 each represent an alkyl group having 1-4 carbon atoms, and R2 represents a hydrogen atom, a hydroxyl group, an alkoxyl group having 1-4 carbon atoms, or a acyloxy group having 2-6 carbon atoms) is further used as a furanone derivative (a).

Abstract: A process for preparing in situ an aqueous gel ink with fixed color comprising the following steps: (i) preparing a gel-based matrix of aqueous ink comprising ester(s) of retinol represented by formula (I), and (ii) adding a solution of gold salts (Au3+) to the gel-based matrix of aqueous ink prepared in step (i), to obtain an aqueous gel ink with fixed color with gold nanoparticles dispersed therein. An aqueous gel ink with fixed color obtained according to the process of the invention, comprising the ester of retinol represented by formula (I) and gold nanoparticles. A writing instrument comprising an aqueous gel ink with fixed color.

Abstract: The present invention relates to an absorbable biomedical composite material and a preparation method therefor, wherein the absorbable biomedical composite material comprises: a substrate particle containing a calcium phosphate compound; an intermediate layer which is coated on the surfaces of the substrate particle and has a first glass transition temperature, the first glass transition temperature being not higher than a normal body temperature; and a polymer matrix which is formed on the outer surface of the intermediate layer and has a second glass transition temperature, the second glass transition being higher than the first glass transition temperature. The present invention can provide an absorbable biomedical composite material which not only increases the mechanical strength but also improves the toughness.

Abstract: An elongated planar or profiled component for a manufacturing machine of a fibrous cellulosic web, such as paper, board or tissue web, is at least partially formed from a composite material having a continuous polymer matrix, and reinforcing inorganic fibers embedded in the continuous polymer matrix. The continuous polymer matrix is biodegradable and the reinforcing inorganic fibers are biodegradable glass fibers. A method is disclosed for recycling elongated planar and/or profiled components used for manufacture of a fibrous web.

Abstract: The present disclosure is related to a method for preparing a gaseous- or liquid-nitridation treated core-shell catalyst and, more specifically, to a method for preparing a gaseous- or liquid-nitridation treated core-shell catalyst comprising steps of: nitridation-treating a transition metal precursor core and noble metal precursor shell particles in the presence of a gaseous nitrogen source; or forming a transition metal precursor core and noble metal precursor shell particles, by means of a liquid nitrogen source, and at the same time allowing the nitrogen source to bond with the transition metal precursor and thus allowing nitridation treatment. Therefore, the present disclosure allows a high nitrogen content in the core and thus enables a prepared catalyst to have excellent durability, a small average particle size and high degree of dispersion and uniformity, and thus to be suitable for the fuel cell field.

Abstract: According to an embodiment, a phase-change memory device comprises: an upper electrode and a lower electrode; a phase-change layer in which a crystal state thereof is changed by heat supplied by the upper electrode and the lower electrode; and a selector which selectively switches the heat supplied by the upper electrode and the lower electrode to the phase-change layer, wherein the selector is formed of a compound which includes a transition metal in the phase-change material so as to have a high resistance when the crystalline state of the selector is crystalline and so as to have a low resistance when the crystalline state of the selector is non-crystalline.

Abstract: Provided are a composite in which metal nanoparticles are evenly dispersed and adsorbed to pores of a support, and a method of preparing the same. An amorphous nanostructure formed of inorganic polymers having a transition metal and a halogen element as a main chain via hydrogen bonding is used as a chemical template for forming the metal nanoparticles. The formed metal nanoparticles are evenly dispersed and adsorbed to the support with pores.